Microbot Medical (MBOT) Competitors $0.92 0.00 (0.00%) (As of 11/20/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends MBOT vs. CRIS, APT, LUCD, NTRB, APYX, CTSO, NXL, MLSS, CLGN, and BLACShould you be buying Microbot Medical stock or one of its competitors? The main competitors of Microbot Medical include Curis (CRIS), Alpha Pro Tech (APT), Lucid Diagnostics (LUCD), Nutriband (NTRB), Apyx Medical (APYX), Cytosorbents (CTSO), Nexalin Technology (NXL), Milestone Scientific (MLSS), CollPlant Biotechnologies (CLGN), and Bellevue Life Sciences Acquisition (BLAC). Microbot Medical vs. Curis Alpha Pro Tech Lucid Diagnostics Nutriband Apyx Medical Cytosorbents Nexalin Technology Milestone Scientific CollPlant Biotechnologies Bellevue Life Sciences Acquisition Curis (NASDAQ:CRIS) and Microbot Medical (NASDAQ:MBOT) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their community ranking, valuation, earnings, dividends, risk, media sentiment, profitability, analyst recommendations and institutional ownership. Does the MarketBeat Community prefer CRIS or MBOT? Curis received 345 more outperform votes than Microbot Medical when rated by MarketBeat users. However, 70.67% of users gave Microbot Medical an outperform vote while only 67.78% of users gave Curis an outperform vote. CompanyUnderperformOutperformCurisOutperform Votes69267.78% Underperform Votes32932.22% Microbot MedicalOutperform Votes34770.67% Underperform Votes14429.33% Does the media refer more to CRIS or MBOT? In the previous week, Curis had 7 more articles in the media than Microbot Medical. MarketBeat recorded 8 mentions for Curis and 1 mentions for Microbot Medical. Curis' average media sentiment score of 0.20 beat Microbot Medical's score of -3.00 indicating that Curis is being referred to more favorably in the media. Company Overall Sentiment Curis Neutral Microbot Medical Very Negative Which has stronger earnings & valuation, CRIS or MBOT? Microbot Medical has lower revenue, but higher earnings than Curis. Microbot Medical is trading at a lower price-to-earnings ratio than Curis, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCuris$10.26M2.16-$47.41M-$7.81-0.47Microbot MedicalN/AN/A-$10.74M-$0.80-1.15 Do analysts prefer CRIS or MBOT? Curis currently has a consensus target price of $23.00, suggesting a potential upside of 521.62%. Microbot Medical has a consensus target price of $7.00, suggesting a potential upside of 660.87%. Given Microbot Medical's higher probable upside, analysts plainly believe Microbot Medical is more favorable than Curis.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Curis 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00Microbot Medical 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Do insiders and institutionals hold more shares of CRIS or MBOT? 30.0% of Curis shares are owned by institutional investors. Comparatively, 16.3% of Microbot Medical shares are owned by institutional investors. 5.7% of Curis shares are owned by company insiders. Comparatively, 10.5% of Microbot Medical shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. Which has more risk and volatility, CRIS or MBOT? Curis has a beta of 3.35, suggesting that its share price is 235% more volatile than the S&P 500. Comparatively, Microbot Medical has a beta of 1.63, suggesting that its share price is 63% more volatile than the S&P 500. Is CRIS or MBOT more profitable? Microbot Medical has a net margin of 0.00% compared to Curis' net margin of -443.35%. Microbot Medical's return on equity of -218.30% beat Curis' return on equity.Company Net Margins Return on Equity Return on Assets Curis-443.35% -923.37% -78.35% Microbot Medical N/A -218.30%-158.17% SummaryCuris beats Microbot Medical on 9 of the 16 factors compared between the two stocks. Ad DTIWhen it comes to NVDA… “acceleration cycles” are the keyExpert options trader Graham Lindman has been working on a new way to tap into Nvidia’s options… By simply isolating outsized “acceleration cycles” within Nvidia stock (most investors don’t even know it exists)... And thanks to many months and late nights working out the kinks of the systems… They have finally found a way to target these cycles on Nvidia over and over again.Use this link to see Nvidia Unchained right away! Get Microbot Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for MBOT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MBOT vs. The Competition Export to ExcelMetricMicrobot MedicalSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$15.65M$4.42B$5.06B$8.82BDividend YieldN/A41.17%5.18%4.07%P/E Ratio-1.1524.81126.3217.81Price / SalesN/A47.011,179.2574.56Price / CashN/A51.8733.8632.53Price / Book2.424.974.684.68Net Income-$10.74M$13.76M$119.54M$226.08M7 Day Performance-3.16%-1.08%-1.83%-1.04%1 Month Performance-7.59%0.58%-3.60%1.04%1 Year Performance-31.85%50.91%31.91%26.28% Microbot Medical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MBOTMicrobot Medical1.7232 of 5 stars$0.92flat$7.00+660.9%-32.8%$15.65MN/A-1.1520Negative NewsCRISCuris2.0186 of 5 stars$3.70-2.4%$23.00+521.6%-56.3%$22.66M$10.02M0.0049APTAlpha Pro TechN/A$5.29-1.1%N/A+11.1%$58.13M$59.29M14.28120LUCDLucid Diagnostics3.221 of 5 stars$1.00+4.2%$3.69+268.8%-23.1%$56.72M$2.43M0.0070NTRBNutriband0.6276 of 5 stars$4.98+1.4%N/A+125.3%$54.53M$2.09M0.0010APYXApyx Medical1.4466 of 5 stars$1.40+9.4%N/A-39.1%$52.70M$48.54M-1.58270CTSOCytosorbents1.2772 of 5 stars$0.92-4.2%$2.00+118.4%-34.6%$52.47M$36.35M0.00186Analyst ForecastGap DownNXLNexalin Technology0.7353 of 5 stars$3.80-2.1%$3.00-21.1%+1,051.5%$49.90M$110,000.000.003MLSSMilestone Scientific2.1757 of 5 stars$0.68+9.7%$1.25+84.4%-15.8%$48.30M$9.83M0.0030Analyst ForecastCLGNCollPlant Biotechnologies1.8582 of 5 stars$4.23+1.0%$11.00+160.0%-24.2%$47.99M$10.96M0.0070Upcoming EarningsBLACBellevue Life Sciences AcquisitionN/A$11.60-0.6%N/A+11.0%$46.86MN/A0.00N/A Related Companies and Tools Related Companies Curis Alternatives Alpha Pro Tech Alternatives Lucid Diagnostics Alternatives Nutriband Alternatives Apyx Medical Alternatives Cytosorbents Alternatives Nexalin Technology Alternatives Milestone Scientific Alternatives CollPlant Biotechnologies Alternatives Bellevue Life Sciences Acquisition Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:MBOT) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Microbot Medical Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Microbot Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
